US4375462A
Expired / Lapsed
US
⏱️ 0.0 years remaining
A-32724 Antibiotics and process for production thereof
Assignee: Eli Lilly and Co
•
Filing: 1981-09-16
•
Granted: 1983-03-01
•
Expires: 2001-09-16
Abstract
Abstract Antibiotic A-32724 complex, comprising microbiologically-active, related factors A, B and C, is produced by submerged, aerobic fermentation of a strain of Chaetomella raphigera Swift NRRL 12331. The A-32724 antibiotics are closely related antibiotics. The individual A-32724 factors are separated by chromatography. In addition to their antibacterial activity, the A-32724 factors inhibit certain enzymes and exhibit antihypertensive properties.
Inventors
- 👤 David H. Berg
- 👤 Marvin M. Hoehn
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 12:09
CPC Classifications
C; C12; C12P; C12P21/00; C12P1/00; C12P1/02; A; A61; A61P; A61P9/00; A61P9/12; C07; C07C; C07C305/00; C07C305/22; C07C305/24; C12N; C12N1/00; C12N1/14; C12N1/145; C12R; C12R2001/00; C12R2001/645; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
288 words
Antibiotic A-32724 Factor A having the following physical and chemical properties: (1) Melting point of about 175°-176° C. (dec.); (2) Molecular weight 738 (determined by nuclear magnetic resonance spectrum, sulfate determination, and field-desorption and electron-impact mass spectrometry); (3) Ultraviolet absorption spectrum in aqueous solution having absorption maxima at 265 nm (ε=333), and 271 nm (sh) (ε=252); (4) Infrared absorption spectrum shown in FIG. 1 as measured by KBr pellet method and having the following distinguishable absorption maxima: 3426 (strong), 2923 (strong), 2852 (strong), 1736 (medium), 1720 (medium), 1616 (medium), 1590 (medium), 1458 (medium), 1383 (shoulder), 1375 (medium weak), 1241 (very strong), 1123 (weak), 1068 (strong), 981 (strong), 884 (weak), 865 (weak), 625 (weak), and 581 cm. -1 (weak); (5) Proton magnetic resonance spectrum in DMSO-d 6 , at 100 MHz, using internal TMS as reference, as follows: ______________________________________
Resonance Chemical No. of
Description
Shift δ, ppm
Protons
______________________________________
Triplet 6.80 1
Doublet 6.74 2
Multiplet 4.67 1
Doublet 4.60 1
(exchangeable)
Multiplet 3.40 1
Triplet ˜2.5 Overlapped
with solvent
Singlet 1.97 3
Multiplet ˜1.5 42
Broad singlet
1.23
Triplet 0.84 3
______________________________________ (6) 13 C Nuclear magnetic resonance spectrum, in DMSO-d 6 , using internal TMS as reference, showing chemical shifts, expressed in parts per million, as follows: ______________________________________
No. PPM
______________________________________
1 170.0
2 153.4
3 142.7
4 115.1
5 110.4
6 75.8
7 70.8
8 35.2
9 32.2
10 31.2
11 30.9
12 29.3
13 29.0
14 28.7
15 28.5
16 25.1
17 25.0
18 22.1
19 20.8
20 13.9
______________________________________ (7) Solubility to solvent: Soluble in water and methanol; (8) Color and form of substance: Amorphous white powder; and (9) An empirical formula of C 33 H 56 O 11 S 2 Na 2 .
Claim 2
Dependent Claim
288 words
Antibiotic A-32724 Factor A having the following physical and chemical properties: (1) Melting point of about 175°-176° C. (dec.); (2) Molecular weight 738 (determined by nuclear magnetic resonance spectrum, sulfate determination, and field-desorption and electron-impact mass spectrometry); (3) Ultraviolet absorption spectrum in aqueous solution having absorption maxima at 265 nm (ε=333), and 271 nm (sh) (ε=252); (4) Infrared absorption spectrum shown in FIG. 1 as measured by KBr pellet method and having the following distinguishable absorption maxima: 3426 (strong), 2923 (strong), 2852 (strong), 1736 (medium), 1720 (medium), 1616 (medium), 1590 (medium), 1458 (medium), 1383 (shoulder), 1375 (medium weak), 1241 (very strong), 1123 (weak), 1068 (strong), 981 (strong), 884 (weak), 865 (weak), 625 (weak), and 581 cm. -1 (weak); (5) Proton magnetic resonance spectrum in DMSO-d 6 , at 100 MHz, using internal TMS as reference, as follows: ______________________________________
Resonance Chemical No. of
Description
Shift δ, ppm
Protons
______________________________________
Triplet 6.80 1
Doublet 6.74 2
Multiplet 4.67 1
Doublet 4.60 1
(exchangeable)
Multiplet 3.40 1
Triplet ˜2.5 Overlapped
with solvent
Singlet 1.97 3
Multiplet ˜1.5 42
Broad singlet
1.23
Triplet 0.84 3
______________________________________ (6) 13 C Nuclear magnetic resonance spectrum, in DMSO-d 6 , using internal TMS as reference, showing chemical shifts, expressed in parts per million, as follows: ______________________________________
No. PPM
______________________________________
1 170.0
2 153.4
3 142.7
4 115.1
5 110.4
6 75.8
7 70.8
8 35.2
9 32.2
10 31.2
11 30.9
12 29.3
13 29.0
14 28.7
15 28.5
16 25.1
17 25.0
18 22.1
19 20.8
20 13.9
______________________________________ (7) Solubility to solvent: Soluble in water and methanol; (8) Color and form of substance: Amorphous white powder; and (9) An empirical formula of C 33 H 56 O 11 S 2 Na 2 .
Claim 3
Dependent Claim
304 words
Antibiotic A-32724 Factor B having the following physical and chemical properties: (1) Melting point of about 160°-162° C. (dec.); (2) Molecular weight 738 (determined by nuclear magnetic resonance spectrum, sulfate determination, and field-desorption and electron-impact mass spectrometry); (3) Ultraviolet absorption spectrum in water solution having absorption maxima at 265 nm (ε=321), and 271 nm (sh) (ε=249); (4) Infrared absorption spectrum shown in FIG. 2 as measured by KBr pellet method and having the following distinguishable absorption maxima: 3468 (strong), 3452 (strong), 2923 (strong), 2853 (strong), 1733 (medium), 1616 (medium), 1591 (medium weak), 1455 (medium), 1376 (weak), 1242 (very strong), 1124 (weak), 1068 (strong), 1032 (shoulder), 980 (strong), 905 (weak), 795 (medium), 767 (medium weak), 721 (weak), 684 (weak), 670 (shoulder), 662 (shoulder), 617 (medium weak), and 579 cm. -1 (medium); (5) Proton magnetic resonance spectrum in DMSO-d 6 , at 100 MHz, using internal TMS as reference, as follows: ______________________________________
Resonance Chemical No. of
Description
Shift δ, ppm Protons
______________________________________
Triplet 6.78 1
Doublet 6.73 2
Multiplet 4.95 1
Multiplet 4.08 1
Triplet ˜2.5 Overlapped
with solvent
Singlet 1.98 3
Multiplet ˜1.5
˜40
Broad singlet
1.23
Triplet 0.85 3
______________________________________ (6) 13 C Nuclear magnetic resonance spectrum, in DMSO-d 6 , using internal TMS as reference, showing chemical shifts, expressed in parts per million, as follows: ______________________________________
No. PPM
______________________________________
1 169.8
2 153.4
3 142.7
4 115.1
5 110.3
6 75.9
7 72.8
8 62.9
9 41.1
10 40.2
11 39.4
12 33.5
13 37.7
14 35.2
15 31.2
16 30.8
17 29.9
18 29.0
19 25.0
20 24.5
21 22.0
22 20.7
23 13.9
24 0.0
______________________________________ (7) Solubility to solvent: Soluble in water and methanol; (8) Color and form of substance: Amorphous white powder; and (9) An empirical formula of C 33 H 56 O 11 S 2 Na 2 .
Claim 4
Dependent Claim
304 words
Antibiotic A-32724 Factor B having the following physical and chemical properties: (1) Melting point of about 160°-162° C. (dec.); (2) Molecular weight 738 (determined by nuclear magnetic resonance spectrum, sulfate determination, and field-desorption and electron-impact mass spectrometry); (3) Ultraviolet absorption spectrum in water solution having absorption maxima at 265 nm (ε=321), and 271 nm (sh) (ε=249); (4) Infrared absorption spectrum shown in FIG. 2 as measured by KBr pellet method and having the following distinguishable absorption maxima: 3468 (strong), 3452 (strong), 2923 (strong), 2853 (strong), 1733 (medium), 1616 (medium), 1591 (medium weak), 1455 (medium), 1376 (weak), 1242 (very strong), 1124 (weak), 1068 (strong), 1032 (shoulder), 980 (strong), 905 (weak), 795 (medium), 767 (medium weak), 721 (weak), 684 (weak), 670 (shoulder), 662 (shoulder), 617 (medium weak), and 579 cm. -1 (medium); (5) Proton magnetic resonance spectrum in DMSO-d 6 , at 100 MHz, using internal TMS as reference, as follows: ______________________________________
Resonance Chemical No. of
Description
Shift δ, ppm Protons
______________________________________
Triplet 6.78 1
Doublet 6.73 2
Multiplet 4.95 1
Multiplet 4.08 1
Triplet ˜2.5 Overlapped
with solvent
Singlet 1.98 3
Multiplet ˜1.5
˜40
Broad singlet
1.23
Triplet 0.85 3
______________________________________ (6) 13 C Nuclear magnetic resonance spectrum, in DMSO-d 6 , using internal TMS as reference, showing chemical shifts, expressed in parts per million, as follows: ______________________________________
No. PPM
______________________________________
1 169.8
2 153.4
3 142.7
4 115.1
5 110.3
6 75.9
7 72.8
8 62.9
9 41.1
10 40.2
11 39.4
12 33.5
13 37.7
14 35.2
15 31.2
16 30.8
17 29.9
18 29.0
19 25.0
20 24.5
21 22.0
22 20.7
23 13.9
24 0.0
______________________________________ (7) Solubility to solvent: Soluble in water and methanol; (8) Color and form of substance: Amorphous white powder; and (9) An empirical formula of C 33 H 56 O 11 S 2 Na 2 .
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-02-28 | 1986-08-30 | 1987-03-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-02-28 | 1990-08-30 | 1991-03-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-02-28 | 1994-08-30 | 1995-03-01 | $7700.00 | Window Closed / Lapsed |